Medicare Coverage Database (MCD)

The draft LCDs are available on the CMS MCD website:

Draft LCDs

When there are draft Local Coverage Determinations (LCDs) that are in the comment period, this webpage will provide a summary of comments received and Noridian's response. This information will remain on this webpage for at least six months.

Status Indicators

D = Draft under development, not yet released for comment
C = Draft LCD released for comment
E = Formal comment period has ended; comments now being considered
F = Final new/revised LCD has been issued for notice
A = Active policy: notice period complete and the policy is in effect

Send Draft LCD Comments to:

Mail:
Noridian Medicare JE Part B
Attention: Draft LCD Comments
PO Box 6781
Fargo, ND 58108-6781
Email: policydraft@noridian.com

X
 
Draft LCD and LCA Title Release Date of Draft LCD for Comment End Date for Comment Period Current Status Comments / Responses Date of Release for Notice Link to Final LCD
Chiropractic Services 06/01/17 08/14/17 E      
Frequency of Hemodialysis

Frequency of Hemodialysis Billing and Coding LCA
10/05/17 12/15/17 F View 01/03/19 View
Helicobacter Pylori Infection Testing

Helicobacter Pylori Infection Testing Billing and Coding LCA
02/01/18 04/13/18 A View 04/11/19 View
Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea

Hypoglossal Nerve Billing and Coding LCA
09/09/19 10/25/19 C      
Lab: Drug Interaction Testing 05/16/19 07/15/19 D      
Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor 06/07/18 08/14/18 F View 02/14/19 View
Micro-Invasive Glaucoma Surgery (MIGS)

MIGS Billing and Coding LCA
09/09/19 10/25/19 C      
MolDX: AlloSure® Cell-Free DNA Testing 10/22/19 12/6/19 C      
MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test 10/04/18 12/14/18 A View 02/28/19 View
MolDX: Combinatorial Pharmacogenomics Limited Coverage 10/22/19 12/6/19 C      
MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Favorable Intermediate Risk Disease 10/22/19 12/6/19 C      
MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Unfavorable Intermediate Risk Disease 05/16/19 07/15/19 D      
MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease 10/04/18 12/14/18 F View 04/11/19 View
MolDX: DecisionDX Melanoma 10/22/19 12/6/19 C      
MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test 10/04/18 12/14/18 A View 04/11/19 View
MolDX: Erythrocyte Molecular Antigen Typing 10/22/19 12/6/19 C      
MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs)

Foodborne Gastrointestinal Panels Billing and Coding LCA
06/01/17 08/14/17 F View 12/27/18 View
MolDX: Genetic Testing for Lynch Syndrome 10/04/18 12/14/18 F View 02/28/19 View
MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Solid Tumors 05/16/19 07/15/19 C      
MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer 10/04/18 12/14/18 A View 04/18/19 View
MolDX: MDS FISH 02/01/18 04/13/18 F View 04/11/19 View
MolDX: Molecular Microscope® Diagnostic System for the Heart 10/22/19 12/6/19 C      
MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels

Multiplex Nuclic Acid Billing and Coding LCA
06/01/17 08/14/17 A View 03/28/19 View
MolDX: myPath Melanoma Assay 10/04/18 12/14/18 F View 04/18/19 View
MolDX: NeuroIDgenetix® Test for Depression 10/04/18 12/14/18 E      
MolDX: Next-Generation Sequencing for Solid Tumors 05/16/19 07/15/19 C      
MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies 05/16/19 07/15/19 C      
MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC) 10/22/19 12/06/19 C      
MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC) 06/07/18 08/14/18 F View 01/15/19 View
MolDX - Pharmacogenomics Testing 10/22/19 12/6/19 C      
MolDX: Pigmented Lesion Assay 05/16/19 07/15/19 C      
MolDX: Prospera 05/16/19 07/15/19 C      
MolDX: Razor 14-Gene Lung Cancer Assay 10/22/19 12/6/19 C      
MolDX: Repeat Germline Testing 10/22/19 12/6/19 C      
MolDX: SelectMDx for Prostate Cancer 10/22/19 12/6/19 C      
MolDX: Signatera and Minimal Residual Disease Testing for Colorectal Cancer 10/22/19 12/6/19 C      
MolDX: Tests on Allograft Kidney Biopsy Tissue to Assess for Graft Rejection 10/22/19 12/6/19 C      
MolDX: TruGraf Blood Gene Expression Test 05/16/19 07/15/19 C      
Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) 06/04/19 07/19/19 D      

 

When a "Draft" LCD becomes "Final/Future," go to the Future LCD page to view a specific future LCD.

  • View All Future LCDs by state. Within the table, each state selection will redirect you to the MCD on the CMS website. Note: All LCDs for JE states are the same.

 

Last Updated Oct 14, 2019